Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Fibrolamellar hepatocellular carcinoma × fludarabine × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 19 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Multiple Myeloma 12 Myelodysplastic Syndromes 11 Lymphoma 11 Lymphoma, Non-Hodgkin 9 Leukemia, Lymphocytic, Chronic, B-Cell 9 Recurrence 8 Lymphoma, Large B-Cell, Diffuse 8 Myeloproliferative Disorders 6 Lymphoma, B-Cell 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Lymphoma, Follicular 5 Leukemia, Biphenotypic, Acute 5 Leukemia 5 Hodgkin Disease 5 Pancreatic Neoplasms 4 Neoplasms 4 Melanoma 4 Lymphoma, Mantle-Cell 4 Hematologic Neoplasms 4 Burkitt Lymphoma 4 Anemia, Refractory, with Excess of Blasts 4 Primary Myelofibrosis 3 Ovarian Neoplasms 3 Lymphoma, B-Cell, Marginal Zone 3 Leukemia, Myelomonocytic, Chronic 3 Urogenital Neoplasms 2 Sarcoma 2 Rhabdomyosarcoma 2

Interventions

poly ICLC 1 pembrolizumab 1 atezolizumab 1 Specimen Handling 1 Sorafenib 1 Nivolumab 1 Irinotecan 1 Ipilimumab 1 DT2216 1 Cyclophosphamide 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡